Fig. 1From: Clinical and immune profiling for cancer of unknown primary siteFlow of the study patients with cancer of unknown primary site. ICI, immune checkpoint inhibitor; IHC, immunohistochemistry; irGEP, immune-related gene expression profilingBack to article page